Tuoxin Pharmaceutical Group Co., Ltd. (301089)

Overview

Tuoxin Pharmaceutical Group Co.,Ltd. is a renowned entity in the pharmaceutical industry that specializes in the research, development, production, and sale of a wide range of pharmaceutical products. The company focuses primarily on chemical synthesis and biological fermentation nucleoside (acid) APIs (Active Pharmaceutical Ingredients), as well as pharmaceutical intermediates. Having expanded its reach beyond the domestic market, Tuoxin Pharmaceutical now caters to clients globally. Founded in the year 2001 and headquartered in Xinxiang, China, the company has established itself as a key player in the pharmaceutical field, providing high-quality products that contribute to the healthcare sector both in China and internationally.

Products and Services

• Purine Base, Pyrimidine Base, Nucleosides, Nucleotide, Deoxynucleosides, Dehyfrated Nucleoside, 2'-modified, Cybinucleoside, and Sugar Series, and Azvudine Intermediate

These products represent a broad array of chemical compounds essential for pharmaceutical formulations, especially in the synthesis of antiviral and anticancer drugs. Their diverse range allows for widespread application in medical treatments and research.

• Disodium 5'-cytidylate, Disodium 5'-uridylate, 5'-Adenosine monophosphate, and D-ribose

These compounds are critical for the synthesis of nucleic acids and energy carriers in the body, facilitating the manufacturing of medications targeted at treating a variety of diseases, from metabolic disorders to viral infections.

• Citicoline Sodium, Ribavirin, Inosine, Acyclovir, Cytosine, 5-Fluorocytosine, Cytidine, and other APIs and pharmaceutical intermediates

These active pharmaceutical ingredients and intermediaries are instrumental in creating a broad spectrum of drugs used in the treatment and management of neurological diseases, viral infections, and cancers, showcasing Tuoxin Pharmaceutical’s extensive contribution to global healthcare needs.